Next
Next Lesson
TACE Global Summit III : The Combination Therapy
Content
Immune landscape after liver directed therapy in hepatocellular carcinoma (HCC) and potential for combination therapy
Current clinical practice and studies of TACE combined with anti-angiogenesis and immunotherapy
Combination Therapy for Hepatocellular Carcinoma - Experience in China
Panelist discussion and Q&A
Immune landscape after liver directed therapy in hepatocellular carcinoma (HCC) and potential for combination therapy
You are unauthorized to view this page.
Username
Password
Remember Me
Forgot Password
